Insite supervised injection site receives Health Canada exemption

Advocates fear new federal legislation will make it harder to open safe injection sites in future

Canada’s first supervised injection site has received a Health Canada exemption that allows it to continue to operate, days after passage of federal legislation that critics fear will make it harder to open new facilities.

Vancouver Coastal Health is required to apply for an annual exemption to operate Insite.

“We know Insite works,” says Coastal Health chief medical health officer Dr. Patricia Daly, in a written statement.

“Thousands of overdose deaths have been prevented, the spread of infectious diseases like HIV and hepatitis C have been reduced, and clients can more easily connect to health services like detox and primary health care,” she says.

Landmark decision

The Conservative government is opposed to the Insite operation and has taken its fight with the supervised injection site to the Supreme Court of Canada.

In a landmark 2011 ruling, the court found that not allowing the clinic to operate would violate the Charter of Rights and Freedoms.

This week the government passed Bill C-2, the Respect for Communities Act.

Daly said the new legislation will make the process of applying for an exemption more onerous, requiring volumes of information to meet 27 conditions.

“VCH is troubled by the numerous conditions set out in the new legislation,” she said.

Donald MacPherson, spokesman for the Canadian Drug Policy Coalition, said he believes the government purposely created Bill C-2 to discourage new sites from opening

“Supervised consumption sites are a response to a very dire situation,” he said.

According to Coastal Health, more than 1.8 million injections have happened at Insite under the supervision of nurses. There have been no overdose deaths, and as many as 800 people visit the facility daily.

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)